Loading...Loading...UnitedHealth Group‘s UNH OptumRx unit has a new pricing model to help manage drug costs for insurers. Starting next year, the OptumRx Clear Trend Guarantee will offer value-based pricing for drugs. It will integrate costs from various sources such as retail pharmacies, home delivery, specialty drugs, and rebates.Value-based pricing means that payments for medicines will be linked to patient outcomes.

正在加载。。。正在加载。。。联合健康集团（UnitedHealth Group）的UNH OptumRx部门有一种新的定价模式，可以帮助管理保险公司的药品成本。从明年开始，OptumRx Clear Trend Guarrance将为药物提供基于价值的定价。它将整合零售药店、送货上门、特种药品和回扣等各种来源的成本。基于价值的定价意味着药品的付款将与患者的结果相关联。

This involves insurers, pharmaceutical companies, and pharmacy benefit management (PBMs) like OptumRx.Related: Analysts Raises Forecasts On UnitedHealth On Controlled Growth Strategy After Cyber Hack.This model aims to provide a more transparent and predictable drug pricing structure. It addresses the complexities and ambiguities in the current system, in which out-of-pocket costs are influenced by a multi-tiered network that includes insurers, drugmakers, pharmacies, and PBMs.This announcement follows OptumRx’s series of measures to promote transparent drug pricing amid growing scrutiny over the role of PBMs in escalating healthcare costs in the United States. PBMs manage prescription drug benefits for health insurance companies, large employers, and Medicare prescription drug plans, a group collectively known as payers.The introduction of the OptumRx Clear Trend Guarantee coincides with similar initiatives from other industry players. Reuters noted that CVS Health Corp CVS recently announced its PBM unit, Caremark, will launch TrueCost, a model designed to offer clients greater visibility into prescription drug pricing and administrative fees. Last month, Cardinal Health, Inc CAH announced that its pharmaceutical distribution contracts with OptumRx, which expire at the end of June 2024, will not be renewed.Price Action: UNH shares are up 0.22% at $518..

这涉及保险公司、制药公司和药房福利管理（PBMs），如OptumRx。相关报道：网络黑客攻击后，分析师上调了对联合健康（UnitedHealth）可控增长战略的预测。该模型旨在提供更透明和可预测的药物定价结构。它解决了当前系统中的复杂性和模糊性，在这个系统中，自付费用受到包括保险公司、制药商、药店和PBM在内的多层网络的影响。在OptumRx采取一系列措施促进药品定价透明化之后，人们对PBM在美国医疗保健成本上升中的作用进行了越来越多的审查。PBM为健康保险公司、大型雇主和医疗保险处方药计划（统称为付款人）管理处方药福利。OptumRx明确趋势担保的推出与其他行业参与者的类似举措相吻合。路透社注意到，CVS Health Corp CVS最近宣布其PBM部门Caremark将推出TrueCost，该模式旨在为客户提供更大的处方药定价和管理费用可见性。上个月，Cardinal Health，Inc CAH宣布，其与OptumRx的药品分销合同将于2024年6月底到期，不会续签。价格走势：UNH股价上涨0.22%，至518美元。。